Fabio Marinho
@fabiomarinhorec
Followers
618
Following
5K
Statuses
4K
Hepatologist and fascinated by it main areas HCC and Steatotic Liver Disease. Humanist, Skeptical and proud father of 2 (email: [email protected]
Recife, northeast of Brazil
Joined November 2013
RT @HepCommJournal: 🚨Approach to Benign #Liver Masses🚨 ⭐️Hemangiomas❕ ⭐️FNH❕ ⭐️Adenomas❕ ⭐️Cysts❕ #LiverTwitter h…
0
83
0
RT @j_livercancer: New in @j_livercancer Microwave ablation versus liver resection for patients with #HCC
#live…
0
3
0
RT @JAMAInternalMed: This Clinical Insights discusses new diagnostic criteria, risk stratification, and emerging treatments of metabolic dy…
0
33
0
RT @bruixj: The failure of response & PFS as surrogates for survival needs to be repeated regularly. Scientific evidence vs marketing with…
0
4
0
RT @A_DAlessioMD: RACB Study: interesting trial design of conversion therapy with AtezoBev in initially unresectable HCC 🩺 However: ❓ PR 13…
0
4
0
RT @ArndtVogel: Development & Validation of a Noninvasive Model for Detection of High-Risk Varices in Unresectable HCC @AGA_CGH
https://t…
0
11
0
RT @ArndtVogel: NIVO + IPI vs LEN or SOR as 1L therapy for unresectable HCC. #ASCOGI25 🔎CheckMate 9DW expanded analyses 👉ORR 36 vs 13% 👉mOS…
0
20
0
RT @ArndtVogel: TACE plus camrelizumab and apatinib vs TACE in HCC #ASCOGI25 🔎CAP-ACE study 👉ORR 65 vs 30% 👉mPFS 3.2 vs 10.8 mo, short PFS…
0
18
0
RT @thiagobarata87: 🚨 12 filmes que chegaram hoje no streaming e você vai querer saber O final de semana chegou! E se você tá procurando o…
0
101
0
RT @ArndtVogel: 🔥Hot off the press: ESMO Clinical Practice Guideline interim update on the management of biliary tract cancer @ESMO_Open h…
0
131
0
RT @scottisaacsmd: ADA Standards of Care in Diabetes—2025: Diagnostic algorithm for risk stratification and the prevention of cirrhosis in…
0
46
0
RT @scottisaacsmd: Cystatin C is a predictor for all-cause and cardiovascular mortality in adults with metabolic syndrome.
0
91
0
RT @massimoiava: Histological predictors of aggressive recurrence* of HCC after liver resection - Journal of Hepatology
0
16
0
RT @BernharScheiner: Outcome of pts with HCC and CR to ICI-therapy @HEP_Journal - full text available 😀 🧑🤝🧑~4% of…
0
7
0
RT @Journal_AHBPS: Primary treatments for solitary hepatocellular carcinoma ≤ 3 cm: A systematic review and network meta-analysis 🌷 https://…
0
7
0
RT @AGA_CGH: Editor's Essential Reading presents Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitorin…
0
9
0
RT @JAMANetworkOpen: Women with MASLD have a higher incidence of cirrhosis, while men with MASLD face greater risks of hepatocellular carci…
0
6
0
RT @JHEP_Reports: 📢JHEP Reports December issue is OUT❕ 🟣10 research articles 🟣3 review articles 🟣1 letter to the editor Don't miss out! S…
0
6
0
RT @scottisaacsmd: Tirzepatide was superior to semaglutide in SURMOUNT-5 a head-to-head trial showing an average weight loss of 20.2% vs. 1…
0
42
0
RT @JAMANetworkOpen: Surgical-based management yields the best outcomes for patients with nonmetastatic hepatocellular carcinoma, while non…
0
3
0